In response to the Food and Drug Administration’s (FDA) proposed rule on prescription drug importation, Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr. released the following statement:
The Healthcare Distribution Alliance (HDA) released the following statement on distribution industry preparedness for the novel COVID-19 “coronavirus” outbreak.
This month, Allied Against Opioid Abuse (AAOA) celebrates its second year of working with stakeholders across the healthcare industry to raise awareness among patients, pharmacists, providers and the public about prescription opioid safety.
The HDA Research Foundation announced Michael Conley, Vice President and Head, Trade Operations and Analytics, Novartis Pharmaceuticals Corporation, as Chairman of its Board of Directors. Craig Cowman, Executive Vice President, Global Sourcing, Cardinal Health, is Vice Chairman.
The Healthcare Distribution Alliance (HDA) Board of Directors’ Executive Committee today announced the appointment of Chester “Chip” Davis, Jr., JD, to the position of President and Chief Executive Officer. Mr. Davis will join HDA during March of this year. Chip joins HDA coming from the Association for Accessible Medicines (AAM), the nation’s leading trade association for manufacturers of generic and biosimilar medicines, where he has served as President and Chief Executive Officer since 2015.
